Differential effects of penicillin binding protein deletion on the susceptibility of Enterococcus faecium to cationic peptide antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 10, 2015, Pages 6132-6139

  Sakoulas, George ^a   Kumaraswamy, Monika ^b   Nonejuie, Poochit ^b   Werth, Brian J ^c,e   Rybak, Micahel J ^c   Pogliano, Joseph ^b   Rice, Louis B ^d   Nizet, Victor ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BETA LACTAM ANTIBIOTIC; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CEFTAROLINE; COLISTIN; DAPTOMYCIN; LINEZOLID; MINOCYCLINE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 5; PENICILLIN BINDING PROTEIN F; PENICILLIN BINDING PROTEIN Z; POLYMYXIN B; RECOMBINANT PROTEIN; TELAVANCIN; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; HUMAN; HUMAN CELL; INNATE IMMUNITY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSITIZATION; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DAPTOMYCIN; ENTEROCOCCUS FAECIUM; MICROBIAL SENSITIVITY TESTS; PENICILLIN-BINDING PROTEINS;

EID: 84942278713     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00486-15     Document Type: Article

References (20)

1. Arias CA, Contreras GA, Murray BE. 2010. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 16:555-562. http://dx.doi.org/10.1111/j.1469-0691.2010.03214.x.
2. Orloff SL, Busch AM, Olyaei AJ, Corless CL, Benner KG, Flora KD, Rosen HR, Rabkin JM. 1999. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg 177:418-422. http://dx.doi.org/10.1016/S0002-9610(99)00083-5.
3. Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA, Papanicolaou G. 2010. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 6:1576-1581. http://dx.doi.org/10.1016/j.bbmt.2010.05.008.
4. Kelesidis T, Humphries Uslan DZ, Pegues DA. 2011. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 52:228-234. http://dx.doi.org/10.1093/cid/ciq113.
5. Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, Nizet V, Yeaman MR, Moise PA. 2012. Ampicillin enhances daptomycin- and cationic host defense peptide-mediate killing of ampicillin and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 56:838-844. http://dx.doi.org/10.1128/AAC.05551-11.
6. Sakoulas G, Rose WE, Nonejuie P, Olson J, Pogliano J, Humphries R, Nizet V. 2014. Ceftaroline restores daptomycin activity of daptomycin-resistant vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 58:1494-1500. http://dx.doi.org/10.1128/AAC.02274-13.
7. Werth BJ, Barber KE, Tran KN, Nonejuie P, Sakoulas G, Pogliano J, Rybak MJ. 2014. Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptibility of daptomycin-susceptible and -resistant VRE. J Antimicrob Chemother 70:489-493. http://dx.doi.org/10.1093/jac/dku386.
8. Henry X, Verlaine O, Amoroso A, Coyette J, Frere JM, Joris B. 2013. Activity of ceftaroline against Enterococcus faecium PBP5. Antimicrob Agents Chemother 57:6358-6360. http://dx.doi.org/10.1128/AAC.00923-13.
9. Rice LB, Carias LL, Rudin S, Hutton R, Marshall S, Hassan M, Josseaume N, Dubost L, Marie A, Arthur M. 2009. Role of class A penicillin-binding proteins in the expression of beta-lactam resistance in E. faecium. J Bacteriol 191:3649-3656. http://dx.doi.org/10.1128/JB.01834-08.
10. Rice LB, Carias LL, Marshall S, Rudin SD, Hutton-Thomas R. 2005. Tn5386, a novel Tn916-like mobile element in Enterococcus faecium D344R that interacts with Tn916 to yield a large genomic deletion. J Bacteriol 187:6668-6677. http://dx.doi.org/10.1128/JB.187.19.6668-6677.2005.
11. Rice LB, Marshall SH, Carias LL. 1992. Tn5381, a conjugative transposon identifiable as a circularform in Enterococcus faecalis. J Bacteriol 174:7308-315.
12. Sakoulas G, Alder J, Thauvin-Eliopoulos, Moellering RC, Jr, Eliopoulos GM. 2006. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother 50:1581-1585. http://dx.doi.org/10.1128/AAC.50.4.1581-1585.2006.
13. Kristian SA, Datta V, Weidenmaier C, Kansal R, Fedtke I, Peschel A, Gallo RL, Nizet V. 2005. D-Alanylation of teichoic acids promotes group A streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol 187:6719-6725. http://dx.doi.org/10.1128/JB.187.19.6719-6725.2005.
14. von Köckritz-Blickwede M, Chow OA, Nizet V. 2009. Fetal calf serum contains heat-stable nucleases that degrade neutrophil extracellular traps. Blood 114:5245-5246. http://dx.doi.org/10.1182/blood-2009-08-240713.
15. Moise PA, Sakoulas G, McKinnell JA, Lamp KC, DePestel DD, Yoon MJ, Reyes K, Zervos MJ. 2015. Effects of concomitant beta-lactam antibiotics on daptomycin treatment outcomes in vancomycin-resistant Enterococcus bacteremia. Clin Ther http://dx.doi.org/10.1016/j.clinthera.2015.04.008.
16. Munita JM, Mishra NN, Alvarez D, Tran TT, Diaz T, Panesso D, Reyes J, Murray BE, Adachi JA, Bayer AS, Arias CA. 2014. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaFSR substitutions. Clin Infect Dis 59:1277-1280. http://dx.doi.org/10.1093/cid/ciu642.
17. Chen CI, Schaller-Bals S, Paul KP, Wahn U, Bals R. 2004. Beta defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibrosis 3:45-50. http://dx.doi.org/10.1016/j.jcf.2003.12.008.
18. Schaller-Bals S, Schulze A, Bals R. 2002. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165:992-995. http://dx.doi.org/10.1164/ajrccm.165.7.200110-020.
19. Tran TT, Panesso D, Mishra NN, Mileykovskaya E, Guan Z, Munita JM, Reyes J, Diaz L, Weinstock GM, Murray BE, Shamoo Y, Dowhan W, Bayer AS, Arias CA. 2013. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids. mBio 4:e00281-13. http://dx.doi.org/10.1128/mBio.00281-13.
20. Sakoulas G, Eliopoulos GM, Fowler Jr, Moellering VG, Jr, Novick RCRP, Lucindo N, Yeaman MR, Bayer AS. 2005. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlate with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother 49:2687-2692. http://dx.doi.org/10.1128/AAC.49.7.2687-2692.2005.